Search

Your search keyword '"Barkaoui, Mohamed"' showing total 130 results

Search Constraints

Start Over You searched for: Author "Barkaoui, Mohamed" Remove constraint Author: "Barkaoui, Mohamed"
130 results on '"Barkaoui, Mohamed"'

Search Results

3. Childhood Langerhans cell histiocytosis hematological involvement: severity associated with BRAFV600E loads

4. Lung transplantation as a rescue option in childhood critical pulmonary Langerhans cell histiocytosis

6. Childhood Langerhans cell histiocytosis with severe lung involvement: a nationwide cohort study

9. Gender and Body Mass Index Difference in Aerobic Capacity: A Study in Moroccan High School Students.

11. Molecular and clinicopathologic characterization of pediatric histiocytoses

16. A Hybrid Genetic Algorithm for the Capacitated Vehicle Routing Problem

17. Molecular and clinicopathologic characterization of pediatric histiocytoses.

18. Cas du Maroc

19. Profil épidémiologique, aspects diagnostiques et évolutifs des patients tuberculeux au centre de diagnostic de la tuberculose et des maladies respiratoires de Settat, Maroc

20. Hematological Involvement in Childhood Langerhans Cell Histiocytosis: A Cohort Study of 303 Patients

21. A circulating subset of BRAF V600E ‐positive cells in infants with high‐risk Langerhans cell histiocytosis treated with BRAF inhibitors

23. The use of plants in the traditional treatment of diabetes patients: survey in southern Morocco.

24. Thymus and mediastinal node involvement in childhood langerhans cell histiocytosis: Long-term follow-up from the French national cohort

26. Chest computed tomography findings for a cohort of children with pulmonary Langerhans cell histiocytosis

27. Long‐term follow‐up of children with risk organ‐negative Langerhans cell histiocytosis after 2‐chlorodeoxyadenosine treatment

30. Distance learning of physical and sports education in the days of the Corona Virus: Case of Morocco

35. A circulating subset of BRAFV600E‐positive cells in infants with high‐risk Langerhans cell histiocytosis treated with BRAF inhibitors.

36. VEMURAFENIB IN CHILDREN WITH REFRACTORY LCH: 53 PATIENTS TREATED IN EU AND LEBANON

38. Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational Study

39. Efficacy of vinblastine in central nervous system Langerhans cell histiocytosis: a nationwide retrospective study

40. Near-optimal search-and-rescue path planning for a moving target.

41. Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort study

42. Circulating cell-free BRAF V600E as a biomarker in children with Langerhans cell histiocytosis

44. BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy.

45. BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy

46. Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30‐year nationwide cohort of 1478 patients under 18 years of age

47. Langerhans cell histiocytosis in children: Correlation of BRAF status with clinical characteristic.

48. Circulating cell-free BRAFV600E as a biomarker in children with Langerhans cell histiocytosis.

Catalog

Books, media, physical & digital resources